Account
Infectious wins Elkoha’s creative duties
MUMBAI: Infectious has been signed on as the communications partner for Tamura Elcomponics Technologies, an Indo-Japanese joint venture between Elcomponics India and Tamura Group, Japan. Infectious will handle the LED lighting brand of the company, Elkoha.
Infectious co-founder and director Ramanuj Shastry said, “LED is on its way to becoming the lighting of the future. We are delighted to partner with Elkoha to usher in a new era of energy-efficient lighting. It’s our dream to make Elkoha a major force in the Indian lighting ecosystem and we shall spare no effort to do so.”
Infectious co-founder and director Nisha Singhania added, “The LED category is at a very nascent stage in India with extremely low awareness and penetration. Elkoha are bringing in best in quality and international standard LED lights to India. We look forward to partnering them in making India energy efficient.”
Elcomponics Group believes in using technology innovatively and responsibly to create a humane luminescent ecosystem for a better and brighter tomorrow.
“We want Elkoha to become a preferred name in the LED lighting space and needed people with who could look at this category as a clean slate, we feel Infectious led by Ramanuj and Nisha will be able to give articulation to our business vision,” said Tamura Elcomponics Tech director Shivendra Dwivedi.
MUMBAI: BigTrunk Communications, an integrated digital marketing agency known for driving brand transformations across industries, has been awarded the digital marketing mandate for Soframycin, one of India’s most trusted antiseptic cream brands from the EncubeEthicals portfolio. With this collaboration, Soframycin makes its debut into the digital space, aiming to amplify its presence across India through compelling social media narratives and data-led campaigns. BigTrunk will lead the brand’s digital strategy and execution, with a focus on connecting Soframycin’s legacy of trust with today’s health-conscious and digitally engaged audience.
Soframycin has been a household name for generations, widely recognized for its efficacy in treating cuts, burns, and wounds. Backed by the scientific rigor and pharmaceutical expertise of EncubeEthicals, a pharmaceutical powerhouse since 1998, the brand benefits from the expertise of over 1,400 professionals, including more than 200 R&D specialists and a robust team of quality experts. With a presence in over 50 countries, Encube’s commitment to excellence in topical formulations adds deep credibility to Soframycin’s legacy. Now, as the brand enters the digital space, BigTrunk Communications will lead the charge in reimagining Soframycin’s story—creating modern, relatable digital experiences that stay true to its heritage.
“As we take Soframycin into its next chapter of growth, embracing digital media is not just a strategy but a necessity. We wanted a partner who could translate our scientific credibility into engaging, relatable content for today’s audience,” said Soframycin vice president – marketing, Ajay Rawal. “BigTrunk’s deep understanding of healthcare communications and digital behavior makes them the ideal partner to build meaningful narratives around wound care, trust, and wellbeing.”
“Soframycin is more than a product—it’s a legacy deeply rooted in care and science,” added BigTrunk Communications founder & managing director Bharat Subramaniam. “We’re excited to take on this responsibility of guiding a heritage brand into the digital world. Our focus will be on creating contextual storytelling and purpose-driven campaigns that bring Soframycin closer to Indian families, both old and new.”
